SRES 910 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
A resolution expressing support for the designation of October 2026 as "Lewy Body Dementia Awareness Month".
Expressing support for the designation of October 2026 as ``Lewy Body Dementia Awareness Month''.
Summary
- Expresses Senate support for designating October 2026 as "Lewy Body Dementia Awareness Month."
- States the Senate's intent to increase awareness and understanding of Lewy body dementia, advocacy for affected individuals and families, and compassion for people living with the disease.
- Expresses the Senate's continued support for research into diagnosis, treatments, and a cure for Lewy body dementia, and for training healthcare providers and emergency personnel to recognize it.
- Recognizes people living with Lewy body dementia and their care partners who take part in clinical trials, and commends the organizations, researchers, healthcare professionals, and volunteers working on the disease.
- As a simple resolution, it expresses the views of the Senate and does not itself create a federal program or change existing law.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
Sen. Booker, Cory A. (D-NJ)
Money behind the sponsor
Top reported contributors to Cory A. Booker’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- Employer not reported $92,425
- PRIME HEALTHCARE $19,800
- APOLLO $15,800
- LOWENSTEIN SANDLER LLP $15,700
- HARVARD UNIVERSITY $14,100
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Cory A. Booker → · Outside spending →
Actions (2)
- Sep 24, 2026 Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5011) · senate
- Sep 24, 2026 Submitted in Senate
Full text
IN THE SENATE OF THE UNITED STATES
September 24, 2026
Mr. Booker submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions
RESOLUTION
Expressing support for the designation of October 2026 as “Lewy Body Dementia Awareness Month”.
Whereas Lewy body dementia—
(1) affects an estimated 1,400,000 individuals in the United States;
(2) is the second most common degenerative dementia;
(3) includes dementia with Lewy bodies and Parkinson’s disease dementia; and
(4) is the most expensive form of dementia;
Whereas the symptoms of Lewy body dementia can include cognitive decline, movement difficulties, visual hallucinations, fluctuations in alertness, REM-sleep behavior disorder (RBD), and autonomic dysfunction; Whereas many people living with Lewy body dementia wait years for a correct diagnosis which can lead to serious patient harm and avoidable health care spending; Whereas there are millions of family members, caregivers, and friends who provide around-the-clock care and support and whose lives are greatly affected by Lewy body dementia; and Whereas more research, education, and support services are needed for the entire Lewy body dementia community now and in the future—
(1) to find better treatments and a cure for Lewy body dementia;
(2) to train healthcare providers and emergency personnel to recognize Lewy body dementia; and
(3) to facilitate early and accurate diagnosis of Lewy body dementia: Now, therefore, be it
Resolved, That the Senate—
(1) expresses support for the designation of the month of October 2026 as “Lewy Body Dementia Awareness Month”;
(2) seeks to increase—
(A) awareness and understanding of Lewy body dementia;
(B) advocates for individuals and families affected by the disease; and
(C) compassion, dignity, and hope for all those living with Lewy body dementia;
(3) continues to support research to diagnose Lewy body dementia and find better treatments and a cure for Lewy body dementia;
(4) recognizes the individuals living with Lewy body dementia and their care partners who participate in vital clinical trials to advance the knowledge of the disease; and
(5) commends the dedication of organizations, volunteers, researchers, healthcare professionals, and millions of individuals across the United States working to improve the quality of life of people living with Lewy body dementia and their families. <all>
Comments